Skip to main content
Top
Published in: AIDS and Behavior 1/2016

01-01-2016 | Brief Report

Proximate Context of HIV Stigma and Its Association with HIV Testing in Sierra Leone: A Population-Based Study

Authors: J. Daniel Kelly, Sheri D. Weiser, Alexander C. Tsai

Published in: AIDS and Behavior | Issue 1/2016

Login to get access

Abstract

The extent to which HIV stigma at the community level remains a barrier to greater uptake in HIV testing services is poorly understood. We used nationally representative data from the 2008 Sierra Leone Demographic and Health Survey. The primary outcome was HIV testing (past 12 months). Our explanatory variable was HIV stigmatizing attitudes (5-item scale). After multivariable adjustment, HIV testing had an inverse association with HIV stigmatizing attitudes measured at the individual [adjusted odds ratio (AOR) 0.94; 95 % CI 0.87–1.01] and community level (AOR 0.70; 95 % CI 0.58–0.85). HIV stigma had a stronger negative association with HIV testing when modeled at the community rather than individual level.
Appendix
Available only for authorised users
Literature
1.
go back to reference Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373(9657):48–57. doi:10.1016/S0140-6736(08)61697-9.PubMedCrossRef Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373(9657):48–57. doi:10.​1016/​S0140-6736(08)61697-9.PubMedCrossRef
4.
go back to reference Tsai AC. Socioeconomic gradients in internalized stigma among 4314 persons with HIV in sub-Saharan Africa. AIDS Behav. 2015;19(2):270–82.PubMedCrossRef Tsai AC. Socioeconomic gradients in internalized stigma among 4314 persons with HIV in sub-Saharan Africa. AIDS Behav. 2015;19(2):270–82.PubMedCrossRef
6.
go back to reference Goffman E. Stigma: notes on the management of spoiled identity. Englewood Cliffs: Prentice-Hall, Inc.; 1963. Goffman E. Stigma: notes on the management of spoiled identity. Englewood Cliffs: Prentice-Hall, Inc.; 1963.
7.
go back to reference Gilmore N, Somerville MA. Stigmatization, scapegoating and discrimination in sexually transmitted diseases: overcoming ‘them’ and ‘us’. Soc Sci Med. 1994;39(9):1339–58.PubMedCrossRef Gilmore N, Somerville MA. Stigmatization, scapegoating and discrimination in sexually transmitted diseases: overcoming ‘them’ and ‘us’. Soc Sci Med. 1994;39(9):1339–58.PubMedCrossRef
10.
go back to reference Konkle-Parker D. Community-level HIV stigma is a public health threat. HIV Clin. 2013;25(2):7–9.PubMed Konkle-Parker D. Community-level HIV stigma is a public health threat. HIV Clin. 2013;25(2):7–9.PubMed
11.
15.
go back to reference Filmer D, Pritchett LH. Estimating wealth effects without expenditure data—or tears: an application to educational enrollments in states of India. Demography. 2011;38(1):115–32. Filmer D, Pritchett LH. Estimating wealth effects without expenditure data—or tears: an application to educational enrollments in states of India. Demography. 2011;38(1):115–32.
Metadata
Title
Proximate Context of HIV Stigma and Its Association with HIV Testing in Sierra Leone: A Population-Based Study
Authors
J. Daniel Kelly
Sheri D. Weiser
Alexander C. Tsai
Publication date
01-01-2016
Publisher
Springer US
Published in
AIDS and Behavior / Issue 1/2016
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-015-1035-9

Other articles of this Issue 1/2016

AIDS and Behavior 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.